What's Going On With Moderna (MRNA) Stock?
Portfolio Pulse from Henry Khederian
Moderna Inc's (NASDAQ:MRNA) shares are trading lower by 2.4% to $113.80. The stock has seen volatility due to rising COVID-19 cases in the U.S. Increased demand for vaccines could potentially drive higher sales of Moderna's vaccine doses. If booster shots are recommended, Moderna's stock could rise from additional vaccine sales. Moderna has a 52-week high of $217.25 and a 52-week low of $95.02.
August 31, 2023 | 6:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Moderna's stock is down 2.4% but could potentially rise due to increased vaccine demand and potential booster shots.
Moderna's stock is currently down, but the rising COVID-19 cases could lead to increased demand for vaccines, potentially driving higher sales of Moderna's vaccine doses. If booster shots are recommended, Moderna's stock could rise as it benefits from additional vaccine sales.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100